Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Cystic fibrosis patients’ vulnerability to COVID-19 infection: Preliminary data ease fears

Publish date:: November 9, 2020

Key clinical point: Clinicians had been concerned about worse outcomes among individuals with cystic fibrosis (CF).

Major finding: A higher proportion of COVID-19–positive patients than the general CF population included Hispanics (18% vs. 9%), Blacks (7% vs. 5%), and individuals with FEV1 value less than 40% predicted (14% vs. 8%).

Study details: Registry analysis.

Disclosures: Dr. Sanders has no relevant financial disclosures.

Citation:

Sanders DB. NACFC 2020.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

Osteoporosis prevalence in PsA similar to general population,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

DOACs look safe in elective endoscopic procedures,

Anorexia and diarrhea top list of GI symptoms in COVID-19 patients,

Must Reads in Pulmonology

E-cigarette use tied to increased COPD, asthma risk,

Obesity, hypoxia predict severity in children with COVID-19,

Telehealth finds acceptance among patients with CF, clinicians,

COVID-19 burdens follow patients after discharge,

Poverty raises depression risk in patients with cystic fibrosis,